Chronic Hydroxychloroquine Therapy and COVID-19 Outcomes: A Retrospective Case-Control Analysis
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
Supplementary Table 1: Home Immunosuppressants
补充表1：家庭用免疫抑制剂
应用场景：
创建时间：
2020-12-22
相关数据集
Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19: Joint guideline of Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia, Sociedade Brasileira de Reumatologia
ABSTRACT Objective: Several therapies are being used or proposed for COVID-19, and many lack appropriate evaluations of their effectiveness and safety. The purpose of this document is to develop recom
DataCite Commons2022-08-16 更新80
Analysis of reported adverse liver reactions associated with drugs used to treat patients with coronavirus disease 2019
Abstract Hepatic injury has been documented in patients with coronavirus disease 2019 (COVID-19). However, pharmacotherapy can frequently impact liver alterations, given the known hepatotoxic potentia
DataCite Commons2023-07-11 更新50
Table4_Discovery of the key active compounds in Citri Reticulatae Pericarpium (Citrus reticulata “Chachi”) and their therapeutic potential for the treatment of COVID-19 based on comparative metabolomics and network pharmacology.xlsx
Edible herbal medicines contain macro- and micronutrients and active metabolites that can take part in biochemical processes to help achieve or maintain a state of well-being. Citri Reticulatae Perica
NIAID Data Ecosystem40
Efficacy of molnupiravir in dwarf hamster model of severe COVID-19. Severe acute respiratory syndrome coronavirus 2
Explanation for the mixed efficacy of molnupiravir in human trials through sex and SARS-CoV-2 variant of concern in dwarf hamster model of severe COVID-19
NIAID Data Ecosystem50
Imatinib in patients with severe COVID-19: a randomised, double-blind, placeb...
Dataset from the CounterCOVID study evaluating the efficacy of oral imatinib in hospitalised patients with COVID-19. Date Submitted: 2022-09-16
B2FIND40
